Ardelyx: Strong IBSRELA Growth, But Heavy Operational Spend Clouds Profitability (ARDX)

Ardelyx, Inc. ( ARDX ) just reported fourth quarter results and actually beat on revenue, but they missed slightly on earnings, which the market took negatively, as you mayI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges behind drug develo ...